# Progress Note 02 — Focused Visit (Follow-up)

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Albert Einstein (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-ET012-SYN-TD
- Date: 1949-04-21
- Fictional facility: St. Posthumous Health Center
- Fictional author: Clementine Ward, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Focused Visit (Follow-up)

## Chief complaint

Four-week follow-up: CT angiography results and vascular surgery consultation the same day. **S**

## History of present illness

Mr. Einstein is a 70-year-old man with a 5.0 cm infrarenal abdominal aortic aneurysm by duplex ultrasound, found and wrapped at a prior exploratory laparotomy, who returns four weeks after his first visit for the CT angiography results and is seen by vascular surgery on the same day. He has had no abdominal, back, or flank pain, fainting, or leg symptoms. He stopped smoking on his quit date a week after the first visit and has had no tobacco for three weeks. He wears the 14 mg patch daily and uses three or four lozenges a day, and he holds an empty, unlit pipe while he works, which he finds helps. He started losartan 50 mg and atorvastatin 40 mg four weeks ago without side effects; his home blood pressure readings average 134/80. The CT angiography two weeks ago showed a 5.2 cm fusiform infrarenal aneurysm with a 2.2 cm neck, calcified atheroma of the aorta and iliac arteries, thickening along the front of the aneurysm from the old wrapping, and no fluid around the aorta. **S**

| Element | Detail |
|---|---|
| Aneurysm | 5.0 cm by ultrasound four weeks ago; 5.2 cm outer-wall diameter on CT angiography two weeks ago |
| Symptoms | None |
| Tobacco | Tobacco-free for three weeks; nicotine patch and lozenges |
| Blood pressure | Home average 134/80 on amlodipine 5 mg and losartan 50 mg |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Cardiovascular | Negative | No chest pain, fainting, or leg pain on walking |
| Gastrointestinal | Negative | No abdominal pain |
| Musculoskeletal | Negative | No back pain; no muscle aches on atorvastatin |
| Respiratory | Negative | Morning cough easing since stopping smoking |

4 systems reviewed. **S**

## Current medications

- Amlodipine 5 mg oral tablet, one tablet daily **S**
- Losartan 100 mg oral tablet, one tablet daily **S**
- Atorvastatin 40 mg oral tablet, one tablet daily **S**
- Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**
- Nicotine 14 mg/24 hour transdermal patch, one patch daily **S**
- Nicotine 2 mg lozenge as needed for cravings **S**

## Allergies

- No known allergy **S**

## Objective

BP 136/82 mmHg; pulse 70 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 97% on room air; weight 78.6 kg; BMI 26.6 kg/m². All vital signs are synthetic.

Sodium: 139 mmol/L; Potassium: 4.6 mmol/L; Creatinine: 1.08 mg/dL; eGFR: 72 mL/min/1.73 m². All results are synthetic.

## Change since baseline

- Sodium: 140 mmol/L at baseline, 139 mmol/L at this visit **S**
- Potassium: 4.3 mmol/L at baseline, 4.6 mmol/L at this visit **S**
- Creatinine: 1.02 mg/dL at baseline, 1.08 mg/dL at this visit **S**
- eGFR: 77 mL/min/1.73 m² at baseline, 72 mL/min/1.73 m² at this visit **S**

## Physical examination

| System | Finding |
|---|---|
| General | Well; weight 78.6 kg |
| Cardiovascular | Regular rhythm at 70 per minute; blood pressure 136/82 mmHg |
| Abdomen | Pulsatile, non-tender mass above the umbilicus; healed midline scar |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Infrarenal abdominal aortic aneurysm under surveillance** (I71.43). Asymptomatic aneurysm of 5.0 cm by ultrasound and 5.2 cm by CT outer-wall measurement, below the 5.5 cm threshold for elective repair in men. The old wrapping does not change the thresholds or the surveillance plan. A shared decision was made with vascular surgery and recorded: surveillance by duplex ultrasound every six months, with elective repair advised at 5.5 cm, growth of 0.5 cm or more in six months, or symptoms, and endovascular repair favored on this anatomy. His preferences are recorded in the consultation. **S**
   - Duplex ultrasound every six months, using ultrasound consistently for comparison.
   - Carry the aneurysm wallet card; emergency plan reviewed.
2. **Atherosclerosis of the abdominal aorta** (I70.0). Calcified atheroma on CT angiography, which supports a high-intensity statin and low-dose aspirin. **S**
   - Start aspirin 81 mg daily with food, as vascular surgery advises.
   - Continue atorvastatin 40 mg.
3. **Essential hypertension** (I10). Above the 130/80 target at the clinic and at home on amlodipine 5 mg and losartan 50 mg; potassium 4.6 and creatinine 1.08 after four weeks of losartan. **S**
   - Increase losartan to 100 mg daily.
   - Metabolic panel and home readings before the three-month visit.
4. **Nicotine dependence, pipe tobacco** (F17.290). Abstinent for three weeks on nicotine replacement. **S**
   - Continue the 14 mg patch and lozenges; quitline support offered.

## Protocol monitoring

Items the monitoring protocol calls for at this visit. **S**

| Domain | Measure | Interval | Status | Detail |
|---|---|---|---|---|
| Imaging | Aneurysm diameter by duplex ultrasound (CT if views are poor) | Every 6 months at 5.0 to 5.4 cm in men; yearly at 4.0 to 4.9 cm | Up to date | 5.0 cm by duplex ultrasound four weeks ago; next scan due at six months |
| Imaging | CT angiography for baseline anatomy and repair planning | Once at baseline; again when repair is considered | Completed today | CT angiography two weeks ago reviewed: 5.2 cm outer-wall diameter, 2.2 cm neck with 30-degree angulation, calcified atheroma, wrap-related thickening, no periaortic fluid; suitable for endovascular repair if needed |
| Examination | Femoral and popliteal arteries for a coexisting aneurysm | Once at diagnosis | Completed today | Vascular surgery examined the femoral and popliteal arteries: normal pulses, no aneurysm felt; a popliteal duplex will be added to the six-month scan |
| Examination | Aneurysm symptoms and tenderness, with the emergency plan reviewed | Every visit | Completed today | No pain, tenderness, or fainting; emergency plan and wallet card reviewed |
| Referral | Vascular surgery review and shared decision on elective repair | At baseline, then at a threshold change or yearly | Completed today | Seen today by vascular surgery: shared decision on thresholds, surveillance, and endovascular versus open repair recorded |
| Examination | Blood pressure, target below 130/80 | Every visit | Completed today | 136/82 mmHg; above target; losartan increased |
| Self-management | Home blood pressure readings | Before each visit while treatment is being adjusted | Completed today | Home average 134/80 over the past week |
| Laboratory | Metabolic panel (sodium, potassium, creatinine, eGFR) | 2 to 4 weeks after starting or changing losartan; then every 6 months | Completed today | Four weeks after starting losartan: sodium 139, potassium 4.6, creatinine 1.08 mg/dL, eGFR 72; repeat after the dose increase |
| Laboratory | Lipid panel | 4 to 12 weeks after starting a statin; then yearly | Due | Atorvastatin started four weeks ago; lipid panel due by twelve weeks after the start |
| Laboratory | ALT | Once before a statin; then only with symptoms | Up to date | 24 U/L before starting atorvastatin |
| Laboratory | HbA1c | Yearly | Up to date | 5.6 percent four weeks ago |
| Laboratory | Urine albumin-to-creatinine ratio | Yearly | Up to date | 14 mg/g four weeks ago |
| Medication safety | Statin adherence and muscle symptoms | Every visit | Completed today | Taking atorvastatin each evening; no muscle aches |
| Medication safety | Low-dose aspirin: indication and bleeding | Every visit while taking it | Completed today | Started today for aortic atheroma; no history of ulcer or bleeding |
| Medication safety | Medication review: avoid fluoroquinolones and anti-inflammatory pain medicines | Every visit | Completed today | No fluoroquinolone or anti-inflammatory use; told to remind any prescriber about the aneurysm |
| Self-management | Tobacco use and cessation support (5 A's, nicotine replacement) | Every visit | Completed today | Tobacco-free for three weeks; 14 mg patch and three or four lozenges a day |
| Examination | 12-lead ECG | Baseline with hypertension; repeat as indicated | Completed today | 12-lead ECG today, requested by vascular surgery and serving as the hypertension baseline: sinus rhythm at 70, normal intervals, no left ventricular hypertrophy or Q waves |
| Examination | Ankle-brachial index | Every 2 to 3 years at 65 or older or with a smoking history | Due | No ankle-brachial index on record; to be done with the six-month duplex scan |
| Examination | Eye examination for hypertensive retinopathy | Yearly | Due | No eye examination in two years; to be arranged at the wellness visit |
| Examination | Weight and BMI | Every visit | Completed today | 78.6 kg; BMI 26.6 |

## Goal progress

- Baseline CT angiography and a vascular surgery consultation, with a documented shared decision about repair thresholds, by the four-week visit. Outcome by 1949-04-21: CT angiography two weeks after the first visit; consultation and shared decision at the four-week visit. **S**
- Blood pressure below 130/80 at the clinic and at home by the three-month visit. In progress; target 1949-07-14. **S**
- LDL cholesterol at least 50 percent lower and below 70 mg/dL by the three-month visit. In progress; target 1949-07-14. **S**
- Tobacco-free by the three-month visit and still at six months. In progress; target 1949-09-22. **S**
- Repeat duplex ultrasound at six months and set the next interval by diameter. In progress; target 1949-09-22. **S**

## Medication changes

- Stopped: Losartan 50 mg oral tablet, one tablet daily **S**
- Started: Losartan 100 mg oral tablet, one tablet daily **S**
- Started: Aspirin 81 mg delayed-release oral tablet, one tablet daily **S**

## Guideline basis

- The Society for Vascular Surgery practice guidelines on the care of patients with an abdominal aortic aneurysm (2018), Society for Vascular Surgery (Journal of Vascular Surgery)
- 2022 ACC/AHA Guideline for the Diagnosis and Management of Aortic Disease (2022), American College of Cardiology and American Heart Association (Circulation)
- CMID: Clinical Monitoring Intelligence Database, Hypertension and Hyperlipidemia monographs (2026), Aether Forge
- Tobacco Smoking Cessation in Adults, Including Pregnant Persons: Interventions (2021), U.S. Preventive Services Task Force

## Follow-up

- Three-month review with the metabolic panel and home blood pressure readings. Duplex ultrasound at six months. **S**
- Next scheduled visit 1949-07-14: three-month review: blood pressure, lipids on a statin, and smoking cessation. **S**
